• Blog
  • Transcatheter Aortic Valve Replacement (TAVR) Market Report

    Transcatheter Aortic Valve Replacement (TAVR) Market Report

    Transcatheter Aortic Valve Replacement (TAVR) Market Report
    Report code - SRHL268 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Transcatheter Aortic Valve Replacement (TAVR) Market, Dynamics, and Market Ana See more...

    Impact of COVID-19 on Transcatheter Aortic Valve Replacement (TAVR) Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Transcatheter Aortic Valve Replacement (TAVR) Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Transcatheter Aortic Valve Replacement (TAVR) Market is projected to grow from USD 7.8 billion in 2020 to USD 21.2 billion by 2026 at a CAGR of over 18.1% during the forecast period.

    Figure: Global Transcatheter Aortic Valve Replacement (TAVR) Market Size, 2020-2026 (USD Billion)

    Transcatheter-Aortic-Valve-Replacement-(TAVR)-Market-Forecast

    Wish to know more about the report? Click here to get a free sample report.

    What is a Transcatheter aortic valve replacement?

    A Transcatheter aortic valve replacement (TAVR), also known as Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgical process that treats the aortic valve by substituting a new biological valve into the old aortic valve’s place without removing the damaged valve. The TAVR method, which is relatively similar to a stent placed in an artery, is carried out by inserting a fully collapsible replacement valve to the aortic valve site with the help of a catheter.

    Key Players

    Key players operating in the global Transcatheter Aortic Valve Replacement (TAVR) market are-

    • Medtronic plc (Ireland),
    • Boston Scientific Corporation (The U.S),
    • Meril Life Sciences Pvt. Ltd., Inc. (India),
    • Edwards Lifesciences Corporation (The U.S),
    • St. Jude Medical, Inc. (The U.S),
    • JenaValve Technology, Inc. (The U.S),
    • Bracco SpA (Italy),
    • Transcatheter Technologies GmbH (Germany),
    • Abbott (The U.S), and
    • Symetis SA (Switzerland).

    Market Dynamics

    A growing number of patients worldwide suffering from cardiovascular diseases such as coronary artery diseases, heart failures, and hypertension is a prime factor bolstering the market growth.

    • Cardiovascular diseases result in improper functioning of aortic valves, which, in turn, accelerates the demand for efficient valve replacement procedures.
    • Also, the rising adoption of TAVR in developing countries offers ample opportunities to the industry participants.
    • However, high risk during surgery and high cost are restraining factors hampering the product demand.

    Segment Analysis

    Procedure Trends

    Based on procedure, the global transcatheter aortic valve replacement market has been segmented into transfemoral implantation, transapical implantation, transaortic implantation, and others.

    • Under these, transfemoral implantation dominated the market in 2020 and is likely to register a steady CAGR in the coming years.
    • This is mainly attributed to advanced technology such as vascular closure systems.
    • This implantation is minimally invasive, enabling faster recovery, thus reducing the overall length of hospital stay, thus drives the segment growth.

    Regional Trends

    By region, the North American market witnessed the largest market share in 2020 and is projected to grow at a significant CAGR during the review period.

    • This is majorly attributed to mergers & acquisitions, high adoption of technologically advanced products, and favourable reimbursement policies.
    • For instance, reimbursement from government groups such as the Centers for Medicare & Medicaid Services (CMS) helps patients to opt for transcatheter aortic valve replacement procedures.

    COVID-19 Impact on Global Transcatheter Aortic Valve Replacement (TAVR) Market

    There has been a more than 50% drop in the number of cardiovascular patients and those diagnosed with myocardial infection post-COVID-19 period, thus affected the TAVR demand. However, the patients who were previously accepted for Surgical Aortic Valve Replacement (SAVR) are now being reconsidered for TAVR which, holds some advantages such as a shorter hospital stay and a reduced need for intensive treatment unit or mechanical ventilation, thus positively influences the market growth.

    Critical Questions Answered in the Report

    • What are the key trends in the global transcatheter aortic valve replacement market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in next five years?
    • What is the impact of COVID-19 on the global transcatheter aortic valve replacement market?
    • What are the key strategies adopted by the major vendors to lead in the global transcatheter aortic valve replacement market?
    • What is the market share of the top vendors?

    To get a customised market report, register here.

    Target Audience

    The following is a list of the customers that the Transcatheter Aortic Valve Replacement (TAVR) market aims to convert the most:

    • Transcatheter aortic valve replacement companies
    • Cardiovascular diseases treatment organizations
    • R&D organizations
    • Hospitals
    • Government organizations

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The transcatheter aortic valve replacement market is expected to witness an impressive growth of 18.1% CAGR in the foreseeable future.

    Medtronic plc (Ireland), Boston Scientific Corporation (The U.S), Meril Life Sciences Pvt. Ltd., Inc. (India), Edwards Lifesciences Corporation (The U.S), St. Jude Medical, Inc. (The U.S), JenaValve Technology, Inc. (The U.S), Bracco SpA (Italy), Transcatheter Technologies GmbH (Germany), Abbott (The U.S) and Symetis SA (Switzerland) are among the key players in the transcatheter aortic valve replacement.

    The transcatheter aortic valve replacement market size is expected to reach USD 21.2 billion in the coming years.

    North America witnessed largest share of the transcatheter aortic valve replacement market in 2020.

    Transfemoral implantation dominated the transcatheter aortic valve replacement market in 2020.

    Growing number of patients worldwide suffering from cardiovascular diseases such as coronary artery diseases, heart failures, and hypertension, rising adoption of TAVR in developing countries are the factors driving the growth of transcatheter aortic valve replacement market.

    Transcatheter aortic valve replacement companies, Cardiovascular diseases treatment organizations, R&D organizations, Hospitals, Government organizations are the target audience in the transcatheter aortic valve replacement market.

    •